Abstract
Aim:
To define the effect of adenosine A1 receptor (A1R) on delta opioid receptor (DOR)-mediated signal transduction.
Methods:
CHO cells stably expressing HA-tagged A1R and DOR-CFP fusion protein were used. The localization of receptors was observed using confocal microscope. DOR-mediated inhibition of adenylyl cyclase was measured using cyclic AMP assay. Western blots were employed to detect the phosphorylation of Akt and the DOR. The effect of A1R agonist N6-cyclohexyladenosine (CHA) on DOR down-regulation was assessed using radioligand binding assay.
Results:
CHA 1 μmol/L time-dependently attenuated DOR agonist [D-Pen2,5]enkephalin (DPDPE)-induced inhibition of intracellular cAMP accumulation with a t1/2=2.56 (2.09–3.31) h. Pretreatment with 1 μmol/L CHA for 24 h caused a right shift of the dose-response curve of DPDPE-mediated inhibition of cAMP accumulation, with a significant increase in EC50 but no change in Emax. Pretreatment with 1 μmol/L CHA for 1 h also induced a significant attenuation of DPDPE-stimulated phosphorylation of Akt. Moreover, CHA time-dependently phosphorylated DOR (Ser363), and this effect was inhibited by A1R antagonist 1,3-Dipropyl-8-cyclopentylxanthine (DPCPX) but not by DOR antagonist naloxone. However, CHA failed to produce the down-regulation of DOR, as neither receptor affinity (Kd) nor receptor density (Bmax) of DOR showed significant change after chronic CHA exposure.
Conclusion:
Activation of A1R by its agonist caused heterologous desensitization of DOR-mediated inhibition of intracellular cAMP accumulation and phosphorylation of Akt. Activation of A1R by its agonist also induced heterologous phosphorylation but not down-regulation of DOR.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Peart JN, Gross GJ . Cross-talk between adenosine and opioid receptors. Drug News Perspect 2005; 18: 237–42.
De Lander GE, Keil GJ 2nd . Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice. J Pharmacol Exp Ther 1994; 268: 943–51.
Peart JN, Gross GJ . Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors. Am J Physiol Heart Circ Physiol 2003; 285: H81–9.
Coupar IM, Tran BL . Withdrawal and bidirectional cross-withdrawal responses in rats treated with adenosine agonists and morphine. Life Sci 2001; 69: 779–90.
Baker SP, Scammells PJ, Belardinelli L . Differential A1-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT(1) MF-2 cells. Br J Pharmacol 2000; 130: 1156–64.
Zhang L, Tetrault J, Wang W, Loh HH, Law PY . Short- and long-term regulation of adenylyl cyclase activity by {delta}-opioid receptor are mediated by G{alpha}i2 in neuroblastoma N2a cells. Mol Pharmacol 2006; 69: 1810–9.
Jajoo S, Mukherjea D, Kumar S, Sheth S, Kaur T, Rybak LP, et al. Role of {beta}-Arrestin1/ERK MAP kinase pathway in regulating adenosine A1 receptor desensitization and recovery. Am J Physiol Cell Physiol 2010; 298: C56–65.
Vendite D, Sanz JM, Lopez-Alanon DM, Vacas J, Andres A, Ros M . Desensitization of adenosine A1 receptor-mediated inhibition of adenylyl cyclase in cerebellar granule cells. Neurochem Res 1998; 23: 211–8.
Kouhen OM, Wang G, Solberg J, Erickson LJ, Law PY, Loh HH . Hierarchical phosphorylation of delta-opioid receptor regulates agonist-induced receptor desensitization and internalization. J Biol Chem 2000; 275: 36659–64.
Law PY, Kouhen OM, Solberg J, Wang W, Erickson LJ, Loh HH . Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor. J Biol Chem 2000; 275: 32057–65.
Qiu Y, Loh HH, Law PY . Phosphorylation of the delta-opioid receptor regulates its beta-arrestins selectivity and subsequent receptor internalization and adenylyl cyclase desensitization. J Biol Chem 2007; 282: 22315–23.
Masri B, Morin N, Pedebernade L, Knibiehler B, Audigier Y . The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments. J Biol Chem 2006; 281: 18317–26.
Navratilova E, Waite S, Stropova D, Eaton MC, Alves ID, Hruby VJ, et al. Quantitative evaluation of human delta opioid receptor desensitization using the operational model of drug action. Mol Pharmacol 2007; 71: 1416–26.
Capra V, Ravasi S, Accomazzo MR, Citro S, Grimoldi M, Abbracchio MP, et al. CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation. J Cell Sci 2005; 118: 5625–36.
Ostasov P, Krusek J, Durchankova D, Svoboda P, Novotny J . Ca2+ responses to thyrotropin-releasing hormone and angiotensin II: the role of plasma membrane integrity and effect of G11alpha protein overexpression on homologous and heterologous desensitization. Cell Biochem Funct 2008; 26: 264–74.
Chen X, Geller EB, Rogers TJ, Adler MW . Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats. Drug Alcohol Depend 2007; 88: 36–41.
Green A, Milligan G, Dobias SB . Gi down-regulation as a mechanism for heterologous desensitization in adipocytes. J Biol Chem 1992; 267: 3223–9.
Shapira M, Gafni M, Sarne Y . Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation. Brain Res 2003; 960: 190–200.
Namir N, Polastron J, Allouche S, Hasbi A, Jauzac P . The delta-opioid receptor in SK-N-BE human neuroblastoma cell line undergoes heterologous desensitization. J Neurochem 1997; 68: 1764–72.
Li Y, Eitan S, Wu J, Evans CJ, Kieffer B, Sun X, et al. Morphine induces desensitization of insulin receptor signaling. Mol Cell Biol 2003; 23: 6255–66.
Okura T, Cowell SM, Varga E, Burkey TH, Roeske WR, Hruby VJ, et al. Differential down-regulation of the human [delta]-opioid receptor by SNC80 and [-Pen2,-Pen5]enkephalin. Eur J Pharmacol 2000; 387: R11–R13.
Marie N, Lecoq I, Jauzac P, Allouche S . Differential sorting of human {delta}-opioid receptors after internalization by peptide and alkaloid agonists. J Biol Chem 2003; 278: 22795–804.
Lecoq I, Marie N, Jauzac P, Allouche S . Different regulation of human delta-opioid receptors by SNC-80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-meth oxybenzyl]-N,N-diethylbenzamide] and endogenous enkephalins. J Pharmacol Exp Ther 2004; 310: 666–77.
Hong MH, Xu C, Wang YJ, Ji JL, Tao YM, Xu XJ, et al. Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization. J Neurochem 2009; 108: 102–14.
Liu JG, Ruckle MB, Prather PL . Constitutively active {micro}-opioid receptors inhibit adenylyl cyclase activity in intact cells and activate G-proteins differently than the agonist [D-Ala2,N-MePhe4,Gly-ol5]enkephalin. J Biol Chem 2001; 276: 37779–86.
Nevo I, Avidor-Reiss T, Levy R, Bayewitch M, Heldman E, Vogel Z . Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors. Mol Pharmacol 1998; 54: 419–26.
Tao YM, Li QL, Zhang CF, Xu XJ, Chen J, Ju YW, et al. LPK-26, a novel [kappa]-opioid receptor agonist with potent antinociceptive effects and low dependence potential. Eur J Pharmacol 2008; 584: 306–11.
Cordeaux Y, Ijzerman AP, Hill SJ . Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist-specific G protein activation. Br J Pharmacol 2004; 143: 705–14.
Shahabi NA, McAllen K, Sharp BM . Delta opioid receptors stimulate Akt-dependent phosphorylation of c-jun in T cells. J Pharmacol Exp Ther 2006; 316: 933–9.
Trapaidze N, Keith DE, Cvejic S, Evans CJ, Devi LA . Sequestration of the delta opioid receptor. Role of the C terminus in agonist-mediated internalization. J Biol Chem 1996; 271: 29279–85.
Ciruela F, Saura C, Canela EI, Mallol J, Lluis C, Franco R . Ligand-induced phosphorylation, clustering, and desensitization of A1 adenosine receptors. Mol Pharmacol 1997; 52: 788–97.
Saura CA, Mallol J, Canela EI, Lluis C, Franco R . Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization. J Biol Chem 1998; 273: 17610–7.
Bailey CP, Connor M . Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 2005; 5: 60–8.
Aguila B, Coulbault L, Boulouard M, Leveille F, Davis A, Toth G, et al. In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance. Br J Pharmacol 2007; 152: 1312–24.
Aley KO, Levine JD . Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal. J Neurosci 1997; 17: 735–44.
Willars GB, Muller-Esterl W, Nahorski SR . Receptor phosphorylation does not mediate cross talk between muscarinic M(3) and bradykinin B(2) receptors. Am J Physiol 1999; 277: C859–69.
Acknowledgements
This study was supported by the National Basic Research Program grant from the Ministry of Science and Technology of China (No G2003CB515400) and (No 2009CB522000), the National Science Fund for Distinguished Young Scholars from the National Natural Science Foundation of China (No 30425002), and a fund granted by the Chinese Academy of Sciences (No KSCXI/YW/R/68).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheng, Y., Tao, Ym., Sun, Jf. et al. Adenosine A1 receptor agonist N6-cyclohexyl-adenosine induced phosphorylation of delta opioid receptor and desensitization of its signaling. Acta Pharmacol Sin 31, 784–790 (2010). https://doi.org/10.1038/aps.2010.70
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2010.70
Keywords
This article is cited by
-
The Agonist of Adenosine A1 Receptor Induced Desensitization of delta Opioid receptor-mediated Raf-1/MEK/ERK Signaling by Feedback Phosphorylation of Raf-1-Ser289/296/301
Neurochemical Research (2023)
-
Pathological cardiac hypertrophy: the synergy of adenylyl cyclases inhibition in cardiac and immune cells during chronic catecholamine stress
Journal of Molecular Medicine (2019)
-
Central activation of the A1 adenosine receptor in fed mice recapitulates only some of the attributes of daily torpor
Journal of Comparative Physiology B (2017)
